RENEE PRIDE, MD
Dermatology Physician in DENVER, Colorado. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
RENEE PRIDE, MD filed 234 Medicare Part D claims in 2023 as a Dermatology Physician in DENVER, Colorado, prescribing 91% generic.
- 234
- Part D claims, 2023
- 91%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
RENEE PRIDE, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
234 49th percentile higher than 49% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
RENEE PRIDE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about RENEE PRIDE, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Colorado
How Dermatology Physician compares to other specialties among Colorado providers
Dermatology Physician share within Colorado
Dermatology Physician is one of the more visible NUCC categories in Colorado
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Dermatology Physician ABMS/AOA estimate
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Dermatology Physician US NPIs
Specialty board-certified rate — Dermatology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RENEE PRIDE, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 4500 E CHERRY CREEK SOUTH DR STE 600, DENVER, CO, 80246, with a listed phone of (303) 355-3000. NPI 1639609480 was issued on 06/14/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PRIDE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 234 prescription claims written by this provider, covering 129 Medicare beneficiaries and totaling roughly $8K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1639609480 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/14/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RENEE PRIDE, MD's current license status, disciplinary history, and board certifications with the Colorado Medical Board in Colorado before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where RENEE PRIDE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RENEE PRIDE, MD. Source: openpaymentsdata.cms.gov.
Total received
$401
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 234 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 252
- Total Day Supply
- 5,903
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $2K
- Generic Drug Cost
- $7K
- Antibiotic Claims
- 44
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 1.35
- Gender Split
- 67% female / 33% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What RENEE PRIDE, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Triamcinolone Acet…
Triamcinolone Acetonide
39 claims
- Ketoconazole
Ketoconazole
35 claims
- Mupirocin
Mupirocin
22 claims
- Clobetasol Propion…
Clobetasol Propionate
21 claims
- Doxycycline Hyclate
Doxycycline Hyclate
17 claims
- Doxycycline Monohy… 14
Doxycycline Monohydrate
14 claims
- Gentamicin Sulfate 14
Gentamicin Sulfate
14 claims
- Metronidazole 14
Metronidazole
14 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 39 |
| Ketoconazole | 35 |
| Mupirocin | 22 |
| Clobetasol Propionate | 21 |
| Doxycycline Hyclate | 17 |
| Doxycycline Monohydrate | 14 |
| Gentamicin Sulfate | 14 |
| Metronidazole | 14 |
| Hydrocortisone | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How RENEE PRIDE, MD fits within the Dermatology Physician landscape nationally.
RENEE PRIDE, MD's 234 claims are below the specialty average of 729.
Nearby Dermatology Physician Providers in Colorado
Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as PRIDE.
Compare Dermatology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Colorado
Frequently Asked Questions
What is RENEE PRIDE, MD's specialty? ▼
How much does RENEE PRIDE, MD prescribe under Medicare Part D? ▼
Where is RENEE PRIDE, MD located? ▼
What is RENEE PRIDE, MD's NPI number? ▼
Does RENEE PRIDE, MD prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does RENEE PRIDE, MD prescribe most often? ▼
Does RENEE PRIDE, MD accept Medicare? ▼
How can I verify RENEE PRIDE, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology